168 related articles for article (PubMed ID: 36949660)
21. Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Kharfan-Dabaja MA; Labopin M; Brissot E; Kroger N; Finke J; Ciceri F; Deconinck E; Blaise D; Chevallier P; Gramatzki M; Ganser A; Stelljes M; Edinger M; Savani B; Ruggeri A; Sanz J; Nagler A; Mohty M
Br J Haematol; 2021 May; 193(3):592-601. PubMed ID: 33838047
[TBL] [Abstract][Full Text] [Related]
22. HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Devillier R; Legrand F; Rey J; Castagna L; Fürst S; Granata A; Charbonnier A; Harbi S; d'Incan E; Pagliardini T; Faucher C; Lemarie C; Saillard C; Calmels B; Mohty B; Maisano V; Weiller PJ; Chabannon C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1449-1454. PubMed ID: 29448057
[TBL] [Abstract][Full Text] [Related]
23. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
[TBL] [Abstract][Full Text] [Related]
24. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
[TBL] [Abstract][Full Text] [Related]
25. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
[TBL] [Abstract][Full Text] [Related]
26. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
[TBL] [Abstract][Full Text] [Related]
27. Current HLA testing recommendations to support HCT.
Yu N; Askar M; Wadsworth K; Gragert L; Fernández-Viña MA
Hum Immunol; 2022 Oct; 83(10):665-673. PubMed ID: 35798627
[TBL] [Abstract][Full Text] [Related]
28. Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.
Petersdorf EW; Malkki M
Semin Hematol; 2005 Apr; 42(2):76-84. PubMed ID: 15846573
[TBL] [Abstract][Full Text] [Related]
29. The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study.
Nagler A; Dholaria B; Labopin M; Bruno B; Rambaldi A; Pioltelli P; La Nasa G; Socié G; Mielke S; Ruggeri M; Saccardi R; Franke GN; Finke J; Savani BN; Ruggeri A; Mohty M
Bone Marrow Transplant; 2021 Jan; 56(1):20-29. PubMed ID: 32561816
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.
Nakane T; Okamura H; Tagaito Y; Koh S; Yoshimura T; Makuuchi Y; Nanno S; Nakamae M; Hirose A; Nakashima Y; Koh H; Hino M; Nakamae H
Int J Hematol; 2019 Dec; 110(6):736-742. PubMed ID: 31560116
[TBL] [Abstract][Full Text] [Related]
31. Donor KIR2DS1-Mediated Decreased Relapse and Improved Survival Depending on Remission Status at HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Ido K; Koh H; Hirose A; Okamura H; Koh S; Nanno S; Nishimoto M; Nakamae M; Nakashima Y; Nakane T; Hino M; Nakamae H
Biol Blood Marrow Transplant; 2020 Apr; 26(4):723-733. PubMed ID: 31899360
[TBL] [Abstract][Full Text] [Related]
32. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
33. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
[TBL] [Abstract][Full Text] [Related]
34. Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study.
Al Hamed R; Ngoya M; Galimard JE; Sengeloev H; Gedde-Dahl T; Kulagin A; Platzbecker U; Yakoub-Agha I; Byrne JL; Valerius T; Socie G; Kröger N; Blaise D; Bazarbachi A; Sanz J; Ciceri F; Nagler A; Mohty M
Cancer; 2023 Sep; 129(17):2645-2654. PubMed ID: 37269074
[TBL] [Abstract][Full Text] [Related]
35. The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.
Dou LP; Zheng H; Wang C; Liu JH; Sun JF; Jin HJ; Gao CJ; Yu L; Da WM
Int J Hematol; 2008 May; 87(4):422-433. PubMed ID: 18347914
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
[TBL] [Abstract][Full Text] [Related]
37. Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Marcoux C; Marin D; Ramdial J; AlAtrash G; Alousi AM; Oran B; Kebriaei P; Popat UR; Rezvani K; Champlin RE; Shpall EJ; Mehta RS
Am J Hematol; 2023 May; 98(5):712-719. PubMed ID: 36734029
[TBL] [Abstract][Full Text] [Related]
38. Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia.
Min GJ; Kim HJ; Kim TG; Hyun YS; Hyun SJ; Baek IC; Yoon SY; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW
HLA; 2020 Oct; 96(4):445-455. PubMed ID: 32506817
[TBL] [Abstract][Full Text] [Related]
39. How to select the best available related or unrelated donor of hematopoietic stem cells?
Tiercy JM
Haematologica; 2016 Jun; 101(6):680-7. PubMed ID: 27252513
[TBL] [Abstract][Full Text] [Related]
40. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
